Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the target of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 417 shares, a drop of 67.8% from the August 15th total of 1,295 shares. Based on an average daily volume of 2,661 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the shares of the company are sold short.
Gyrodyne Price Performance
Shares of NASDAQ:GYRO traded up $0.07 on Friday, hitting $5.06. The company had a trading volume of 13,130 shares, compared to its average volume of 3,040. The stock has a 50 day moving average price of $5.50 and a 200 day moving average price of $6.77. Gyrodyne has a 1-year low of $4.95 and a 1-year high of $10.90.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Gyrodyne stock. Susquehanna International Group LLP acquired a new position in shares of Gyrodyne , LLC (NASDAQ:GYRO – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 14,186 shares of the real estate investment trust’s stock, valued at approximately $142,000. Susquehanna International Group LLP owned about 0.65% of Gyrodyne as of its most recent SEC filing. 71.36% of the stock is owned by institutional investors.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
